DZ Bank Aktienanleihe SY1 25.09.2.../ DE000DJ7BYL5 /
13/06/2024 21:34:29 | Diferencia-0.120 | Bid9:03:28 | Ask9:03:28 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
100.700EUR | -0.12% | 100.680 Volumen de oferta: 100,000 |
100.780 Tamaño/ Volumen/ Formato de Ask: 100,000 |
SYMRISE AG INH. O.N. | 100.00 - | 25/09/2024 | Call |
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página